Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.

Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H.

Cancer Sci. 2013 Nov;104(11):1539-43. doi: 10.1111/cas.12245. Epub 2013 Sep 6.

2.

An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.

Shui R, Yu B, Bi R, Yang F, Yang W.

PLoS One. 2015 May 1;10(5):e0125131. doi: 10.1371/journal.pone.0125131. eCollection 2015.

3.

A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.

Zhong F, Bi R, Yu B, Yang F, Yang W, Shui R.

PLoS One. 2016 Feb 29;11(2):e0150505. doi: 10.1371/journal.pone.0150505. eCollection 2016.

4.

Assessment of the Ki67 labeling index: a Japanese validation ring study.

Niikura N, Sakatani T, Arima N, Ohi Y, Honma N, Kanomata N, Yoshida K, Kadoya T, Tamaki K, Kumaki N, Iwamoto T, Sugie T, Moriya T.

Breast Cancer. 2016 Jan;23(1):92-100. doi: 10.1007/s12282-014-0536-0. Epub 2014 May 3.

PMID:
24794952
5.

Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.

Maeda I, Abe K, Koizumi H, Nakajima C, Tajima S, Aoki H, Tsuchiya J, Tsuchiya S, Tsuchiya K, Shimo A, Tsugawa K, Ueno T, Tatsunami S, Takagi M.

Breast Cancer. 2016 Sep;23(5):745-51. doi: 10.1007/s12282-015-0634-7. Epub 2015 Aug 14.

PMID:
26271611
6.

Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.

Hida AI, Bando K, Sugita A, Maeda T, Ueda N, Matsukage S, Nakanishi M, Kito K, Miyazaki T, Ohtsuki Y, Oshiro Y, Inoue H, Kawaguchi H, Yamashita N, Aogi K, Moriya T.

J Clin Pathol. 2015 May;68(5):356-61. doi: 10.1136/jclinpath-2014-202695. Epub 2015 Feb 11.

PMID:
25673730
7.

Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.

Tang LH, Gonen M, Hedvat C, Modlin IM, Klimstra DS.

Am J Surg Pathol. 2012 Dec;36(12):1761-70. doi: 10.1097/PAS.0b013e318263207c.

PMID:
23026928
8.

Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells.

Hida AI, Oshiro Y, Inoue H, Kawaguchi H, Yamashita N, Moriya T.

Breast Cancer. 2015 Mar;22(2):129-34. doi: 10.1007/s12282-013-0460-8. Epub 2013 Mar 31.

PMID:
23543399
9.

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists.

Varga Z, Diebold J, Dommann-Scherrer C, Frick H, Kaup D, Noske A, Obermann E, Ohlschlegel C, Padberg B, Rakozy C, Sancho Oliver S, Schobinger-Clement S, Schreiber-Facklam H, Singer G, Tapia C, Wagner U, Mastropasqua MG, Viale G, Lehr HA.

PLoS One. 2012;7(5):e37379. doi: 10.1371/journal.pone.0037379. Epub 2012 May 25.

10.

An international Ki67 reproducibility study.

Polley MY, Leung SC, McShane LM, Gao D, Hugh JC, Mastropasqua MG, Viale G, Zabaglo LA, Penault-Llorca F, Bartlett JM, Gown AM, Symmans WF, Piper T, Mehl E, Enos RA, Hayes DF, Dowsett M, Nielsen TO; International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.

J Natl Cancer Inst. 2013 Dec 18;105(24):1897-906. doi: 10.1093/jnci/djt306. Epub 2013 Nov 7.

11.

Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values.

Cserni G, Vörös A, Liepniece-Karele I, Bianchi S, Vezzosi V, Grabau D, Sapino A, Castellano I, Regitnig P, Foschini MP, Zolota V, Varga Z, Figueiredo P, Decker T, Focke C, Kulka J, Kaya H, Reiner-Concin A, Amendoeira I, Callagy G, Caffrey E, Wesseling J, Wells C.

Breast. 2014 Jun;23(3):259-63. doi: 10.1016/j.breast.2014.02.003. Epub 2014 Mar 7.

12.

Variability in measuring the Ki-67 labeling index in patients with breast cancer.

Yamamoto S, Chishima T, Mastubara Y, Adachi S, Harada F, Toda Y, Arioka H, Hasegawa N, Kakuta Y, Sakamaki K.

Clin Breast Cancer. 2015 Feb;15(1):e35-9. doi: 10.1016/j.clbc.2014.09.005. Epub 2014 Oct 22.

PMID:
25445422
13.
14.

The use of digital images improves reproducibility of the ki-67 labeling index as a proliferation marker in breast cancer.

Vörös A, Csörgő E, Kővári B, Lázár P, Kelemen G, Cserni G.

Pathol Oncol Res. 2014 Apr;20(2):391-7. doi: 10.1007/s12253-013-9708-z. Epub 2013 Nov 8.

PMID:
24202856
15.

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies.

Fasanella S, Leonardi E, Cantaloni C, Eccher C, Bazzanella I, Aldovini D, Bragantini E, Morelli L, Cuorvo LV, Ferro A, Gasperetti F, Berlanda G, Dalla Palma P, Barbareschi M.

Diagn Pathol. 2011 Mar 30;6 Suppl 1:S7. doi: 10.1186/1746-1596-6-S1-S7.

16.

A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.

Laurinavicius A, Plancoulaine B, Laurinaviciene A, Herlin P, Meskauskas R, Baltrusaityte I, Besusparis J, Dasevicius D, Elie N, Iqbal Y, Bor C.

Breast Cancer Res. 2014;16(2):R35.

17.

Predictive value of Ki67 for adjuvant chemotherapy in node-negative, hormone receptor-positive breast cancer.

Sutepvarnon A, Warnnissorn M, Srimuninnimit V.

J Med Assoc Thai. 2013 Feb;96 Suppl 2:S60-6.

PMID:
23590023
18.

Interobserver Variability of Ki-67 Measurement in Breast Cancer.

Chung YR, Jang MH, Park SY, Gong G, Jung WH; Korean Breast Pathology Ki-67 Study Group.

J Pathol Transl Med. 2016 Mar;50(2):129-37. doi: 10.4132/jptm.2015.12.24. Epub 2016 Feb 15.

19.

Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.

Lehr HA, Hansen DA, Kussick S, Li M, Hwang H, Krummenauer F, Trouet S, Gown AM.

Hum Pathol. 1999 Nov;30(11):1314-20.

PMID:
10571511
20.

Ki67 and proliferation in breast cancer.

Pathmanathan N, Balleine RL.

J Clin Pathol. 2013 Jun;66(6):512-6. doi: 10.1136/jclinpath-2012-201085. Epub 2013 Feb 22. Review.

PMID:
23436927

Supplemental Content

Support Center